186 related articles for article (PubMed ID: 9029406)
1. Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin.
Gudelsky GA
J Neural Transm (Vienna); 1996; 103(12):1397-404. PubMed ID: 9029406
[TBL] [Abstract][Full Text] [Related]
2. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
Shankaran M; Yamamoto BK; Gudelsky GA
Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.
Darvesh AS; Gudelsky GA
Brain Res; 2005 Sep; 1056(2):168-75. PubMed ID: 16098955
[TBL] [Abstract][Full Text] [Related]
4. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain.
Jones DC; Duvauchelle C; Ikegami A; Olsen CM; Lau SS; de la Torre R; Monks TJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):422-31. PubMed ID: 15634943
[TBL] [Abstract][Full Text] [Related]
6. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.
Shankaran M; Gudelsky GA
Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.
Baumann MH; Clark RD; Franken FH; Rutter JJ; Rothman RB
Neuroscience; 2008 Mar; 152(3):773-84. PubMed ID: 18313226
[TBL] [Abstract][Full Text] [Related]
8. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
Rodsiri R; Green AR; Marsden CA; Fone KC
J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
[TBL] [Abstract][Full Text] [Related]
9. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
10. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
Wang X; Baumann MH; Dersch CM; Rothman RB
Neuroscience; 2007 Aug; 148(1):212-20. PubMed ID: 17629409
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate.
Nixdorf WL; Burrows KB; Gudelsky GA; Yamamoto BK
J Neurochem; 2001 Apr; 77(2):647-54. PubMed ID: 11299327
[TBL] [Abstract][Full Text] [Related]
12. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies.
Lew R; Sabol KE; Chou C; Vosmer GL; Richards J; Seiden LS
J Pharmacol Exp Ther; 1996 Feb; 276(2):855-65. PubMed ID: 8632359
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
Darvesh AS; Yamamoto BK; Gudelsky GA
J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837
[TBL] [Abstract][Full Text] [Related]
14. Differential role of dose and environment in initiating and intensifying neurotoxicity caused by MDMA in rats.
Shokry IM; Shields CJ; Callanan JJ; Ma Z; Tao R
BMC Pharmacol Toxicol; 2019 Aug; 20(1):47. PubMed ID: 31383036
[TBL] [Abstract][Full Text] [Related]
15. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
Colado MI; Green AR
Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
[TBL] [Abstract][Full Text] [Related]
16. Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.
Goñi-Allo B; Ramos M; Herv'as I; Lasheras B; Aguirre N
J Psychopharmacol; 2006 Mar; 20(2):245-56. PubMed ID: 16510482
[TBL] [Abstract][Full Text] [Related]
17. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY
Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
[TBL] [Abstract][Full Text] [Related]
18. Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine.
Gudelsky GA; Yamamoto BK
Methods Mol Med; 2003; 79():55-73. PubMed ID: 12506690
[TBL] [Abstract][Full Text] [Related]
19. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
Hervías I; Lasheras B; Aguirre N
J Neurochem; 2000 Sep; 75(3):982-90. PubMed ID: 10936179
[TBL] [Abstract][Full Text] [Related]
20. Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.
Colado MI; O'Shea E; Granados R; Esteban B; Martín AB; Green AR
Br J Pharmacol; 1999 Feb; 126(4):911-24. PubMed ID: 10193771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]